Dulaglutide: The REWIND trial provided strong evidence that dulaglutide could reduce the risk of major cardiovascular events, such as heart attack or stroke, by 12% in patients with or at risk of heart disease
Any information presented on this site is for educational and scientific reference only and does not constitute medical advice, dosing recommendations, or claims of safety or efficacy in humans
Its a team effort between the medication and the persons lifestyle choices
In a clinical trial of people with Type 2 Diabetes, a group known to be deficient in glutathione, liposomal glutathione was given for three months
The Wegovy injection presents an effective weekly option using a pre-filled pen, while the oral Wegovy pill, with the same active ingredient, presents a convenient daily alternative
If osmotic and stool-softening options prove insufficient, discuss prescription options like linaclotide (Linzess) or plecanatide (Trulance) with your healthcare providerthese are gut-selective agents that may be safer in GLP-1 users than older stimulants